fibrinolysins activate
纤溶酶原激活
administering fibrinolysins
给药纤溶酶原
fibrinolysin levels
纤溶酶原水平
measuring fibrinolysins
测量纤溶酶原
fibrinolysin treatment
纤溶酶原来治
inhibiting fibrinolysins
抑制纤溶酶原
fibrinolysins degrade
纤溶酶原降解
detecting fibrinolysins
检测纤溶酶原
fibrinolysin activity
纤溶酶原来动
increased fibrinolysins
增加的纤溶酶原
researchers are investigating the potential of fibrinolysins for treating ischemic stroke.
研究人员正在调查纤维蛋白溶菌酶在治疗缺血性中风方面的潜力。
fibrinolysins can effectively dissolve blood clots in the circulatory system.
纤维蛋白溶菌酶可以有效地溶解循环系统中的血栓。
the development of novel fibrinolysins is a key area of pharmaceutical research.
新型纤维蛋白溶菌酶的开发是制药研究的关键领域。
administering fibrinolysins requires careful monitoring of patient coagulation status.
给药纤维蛋白溶菌酶需要仔细监测患者的凝血状态。
engineered fibrinolysins offer improved efficacy and reduced bleeding risks.
工程化纤维蛋白溶菌酶提供改进的有效性和降低的出血风险。
fibrinolysins' mechanism of action involves the breakdown of fibrin networks.
纤维蛋白溶菌酶的作用机制涉及纤维蛋白网络的分解。
clinical trials are evaluating the safety and efficacy of recombinant fibrinolysins.
临床试验正在评估重组纤维蛋白溶菌酶的安全性和有效性。
the rapid onset of action is a significant advantage of certain fibrinolysins.
快速起效是某些纤维蛋白溶菌酶的一个重要优势。
understanding fibrinolysins' interactions with other clotting factors is crucial.
理解纤维蛋白溶菌酶与其他凝血因子之间的相互作用至关重要。
fibrinolysins are being explored as a potential treatment for deep vein thrombosis.
纤维蛋白溶菌酶被探索作为治疗深静脉血栓形成的一种潜在方法。
the stability of fibrinolysins in storage is an important consideration for manufacturers.
制造商需要考虑纤维蛋白溶菌酶在储存中的稳定性。
fibrinolysins activate
纤溶酶原激活
administering fibrinolysins
给药纤溶酶原
fibrinolysin levels
纤溶酶原水平
measuring fibrinolysins
测量纤溶酶原
fibrinolysin treatment
纤溶酶原来治
inhibiting fibrinolysins
抑制纤溶酶原
fibrinolysins degrade
纤溶酶原降解
detecting fibrinolysins
检测纤溶酶原
fibrinolysin activity
纤溶酶原来动
increased fibrinolysins
增加的纤溶酶原
researchers are investigating the potential of fibrinolysins for treating ischemic stroke.
研究人员正在调查纤维蛋白溶菌酶在治疗缺血性中风方面的潜力。
fibrinolysins can effectively dissolve blood clots in the circulatory system.
纤维蛋白溶菌酶可以有效地溶解循环系统中的血栓。
the development of novel fibrinolysins is a key area of pharmaceutical research.
新型纤维蛋白溶菌酶的开发是制药研究的关键领域。
administering fibrinolysins requires careful monitoring of patient coagulation status.
给药纤维蛋白溶菌酶需要仔细监测患者的凝血状态。
engineered fibrinolysins offer improved efficacy and reduced bleeding risks.
工程化纤维蛋白溶菌酶提供改进的有效性和降低的出血风险。
fibrinolysins' mechanism of action involves the breakdown of fibrin networks.
纤维蛋白溶菌酶的作用机制涉及纤维蛋白网络的分解。
clinical trials are evaluating the safety and efficacy of recombinant fibrinolysins.
临床试验正在评估重组纤维蛋白溶菌酶的安全性和有效性。
the rapid onset of action is a significant advantage of certain fibrinolysins.
快速起效是某些纤维蛋白溶菌酶的一个重要优势。
understanding fibrinolysins' interactions with other clotting factors is crucial.
理解纤维蛋白溶菌酶与其他凝血因子之间的相互作用至关重要。
fibrinolysins are being explored as a potential treatment for deep vein thrombosis.
纤维蛋白溶菌酶被探索作为治疗深静脉血栓形成的一种潜在方法。
the stability of fibrinolysins in storage is an important consideration for manufacturers.
制造商需要考虑纤维蛋白溶菌酶在储存中的稳定性。
探索常用高频词汇